WALTHAM, Mass.--(BUSINESS WIRE)--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that OXiGENE President and CEO, Dr. Richard Chin, will present at the Lazard Capital Markets Fourth Annual Healthcare Conference at the New York Palace Hotel in New York City on Wednesday, November 28, at 9:30 a.m. EST / 6:30 a.m. PST.
